<DOC>
	<DOCNO>NCT00780962</DOCNO>
	<brief_summary>Multiple agent study prevent radiocontrast nephropathy administration radiocontrast agent . One agents N-acetylcysteine . Previous trial assess efficacy n-acetylcystenine prevention contrast nephropathy promising . Previous work field limited applicability Emergency Department ( ED ) patient population two reason : 1 . Many pretreatment strategy employ study take several hour even day perform , feasible acutely ill ED patient . 2 . Most study conduct patient undergoing cardiac catheterization . This may different population patient ED undergo abdominal chest compute tomography . We wish study efficacy N-acetylcysteine agent prevent radiocontrast nephropathy ED patient undergo computerized tomography . We propose randomize , double-blind , control trial compare saline hydration plus N-acetylcysteine versus saline hydration alone . The hypothesis study N-acetylcysteine normal saline effective saline alone prevention radiocontrast nephropathy .</brief_summary>
	<brief_title>N-Acetylcysteine Prevent Radiocontrast Nephropathy Emergency Department Patients</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Undergoing CT intravenous contrast part clinical care 18 year age old Willingness serum creatinine measure 4872 hour study Presence one risk factor radiocontrast nephropathy : Creatinine great equal 1.4 mg/dL Estimated Glomerular Filtration Rate ( eGFR ) less 60 mL/min/1.73m2 Diabetes Mellitus Hypertension treat antihypertensive mediation Coronary artery disease Concurrent use follow nephrotoxic drug : Cyclosporine A Aminoglycosides Amphotericin Cisplatin Nonsteroidal antiinflammatory drug Congestive heart failure ( active history ) Older age ( 65 year age old ) Anemia ( hematocrit &lt; 30 % ) Unable unwilling provide inform consent Endstage renal disease currently undergo regular hemodialysis Pregnant Known allergy Nacetylcysteine Too unstable wait infusion medication placebo Treating physician use NAcetylcysteine part clincial care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>NAC</keyword>
	<keyword>Radiocontrast Nephropathy</keyword>
	<keyword>N-Acetycysteine</keyword>
	<keyword>RCN</keyword>
	<keyword>RCIN</keyword>
	<keyword>Creatinine</keyword>
	<keyword>Computerized Tomography</keyword>
	<keyword>CT</keyword>
	<keyword>Emergency Department</keyword>
	<keyword>ED</keyword>
	<keyword>Safety IV N-Acetylcysteine</keyword>
</DOC>